van der Zee HH - Search Results

1

External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa Cohort.

van Straalen KR, Tzellos T, Alavi A, Benhadou F, Cuenca-Barrales C, Daxhelet M, Daoud M, Efthymiou O, Giamarellos-Bourboulis EJ, Guillem P, Gulliver W, Jemec GBE, Katoulis A, Koenig A, Lazaridou E, Lowes MA, Marzano AV, Matusiak L, Molina-Leyva A, Moltrasio C, Pinter A, Potenza C, Prens EP, Romaní J, Saunte DM, Sayed C, Skroza N, Stergianou D, Szepietowski JC, Trigoni A, Vilarrasa E, Kyrgidis A, Zouboulis CC, van der Zee HH. van Straalen KR, et al. Among authors: van der zee hh. Dermatology. 2023;239(3):362-367. doi: 10.1159/000528968. Epub 2023 Jan 30. Dermatology. 2023. PMID: 36630943 Free article.

2

Depression in patients with hidradenitis suppurativa.

Onderdijk AJ, van der Zee HH, Esmann S, Lophaven S, Dufour DN, Jemec GB, Boer J. Onderdijk AJ, et al. Among authors: van der zee hh. J Eur Acad Dermatol Venereol. 2013 Apr;27(4):473-8. doi: 10.1111/j.1468-3083.2012.04468.x. Epub 2012 Feb 20. J Eur Acad Dermatol Venereol. 2013. PMID: 22339940

3

[Diagnostic image (319). A man with multiple yellow nodules].

van der Zee HH, van de Scheur MR. van der Zee HH, et al. Among authors: van de scheur mr. Ned Tijdschr Geneeskd. 2007 Apr 14;151(15):862. Ned Tijdschr Geneeskd. 2007. PMID: 17472117 Dutch.

4

Weekly adalimumab treatment decreased disease flare in hidradenitis suppurativa over 36 weeks: integrated results from the phase 3 PIONEER trials.

van der Zee HH, Longcore M, Geng Z, Garg A. van der Zee HH, et al. J Eur Acad Dermatol Venereol. 2020 May;34(5):1050-1056. doi: 10.1111/jdv.16023. Epub 2019 Nov 19. J Eur Acad Dermatol Venereol. 2020. PMID: 31630445 Free PMC article.

5

The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa.

van der Zee HH, Boer J, Prens EP, Jemec GB. van der Zee HH, et al. Dermatology. 2009;219(2):143-7. doi: 10.1159/000228337. Epub 2009 Jul 8. Dermatology. 2009. PMID: 19590174 Free article.

6

Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study.

van der Zee HH, van der Woude CJ, Florencia EF, Prens EP. van der Zee HH, et al. Among authors: van der woude cj. Br J Dermatol. 2010 Jan;162(1):195-7. doi: 10.1111/j.1365-2133.2009.09430.x. Epub 2009 Aug 14. Br J Dermatol. 2010. PMID: 19681876

7

Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions.

van der Zee HH, Prens EP, Boer J. van der Zee HH, et al. J Am Acad Dermatol. 2010 Sep;63(3):475-80. doi: 10.1016/j.jaad.2009.12.018. J Am Acad Dermatol. 2010. PMID: 20708472

8

Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β.

van der Zee HH, de Ruiter L, van den Broecke DG, Dik WA, Laman JD, Prens EP. van der Zee HH, et al. Among authors: van den broecke dg. Br J Dermatol. 2011 Jun;164(6):1292-8. doi: 10.1111/j.1365-2133.2011.10254.x. Epub 2011 May 17. Br J Dermatol. 2011. PMID: 21332464

9

The anti-inflammatory drug colchicine lacks efficacy in hidradenitis suppurativa.

van der Zee HH, Prens EP. van der Zee HH, et al. Dermatology. 2011;223(2):169-73. doi: 10.1159/000332846. Epub 2011 Oct 13. Dermatology. 2011. PMID: 21997700 Clinical Trial.

10

Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study.

van der Zee HH, Laman JD, de Ruiter L, Dik WA, Prens EP. van der Zee HH, et al. Br J Dermatol. 2012 Feb;166(2):298-305. doi: 10.1111/j.1365-2133.2011.10698.x. Br J Dermatol. 2012. PMID: 22013960

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page